Previous close | 212.60 |
Open | 211.60 |
Bid | 209.80 x N/A |
Ask | 211.50 x N/A |
Day's range | 210.70 - 211.60 |
52-week range | 166.20 - 238.00 |
Volume | |
Avg. volume | 0 |
Market cap | 38.39B |
Beta (5Y monthly) | 1.53 |
PE ratio (TTM) | 31.35 |
EPS (TTM) | 6.72 |
Earnings date | 30 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
RESEARCH TRIANGLE PARK, N.C., May 14, 2024--Overall spending in the U.S. market for medicines grew by 2.5% and reached $435Bn in 2023. Excluding the contribution from COVID-19 vaccines and therapeutics, spending grew at 9.9%, according to a new report from the IQVIATM Institute for Human Data Science, The Use of Medicines in the U.S. 2024: Usage and Spending Trends and Outlook to 2028.
Let's talk about the popular IQVIA Holdings Inc. ( NYSE:IQV ). The company's shares saw a double-digit share price rise...